Package 50268-615-13

Brand: olanzapine

Generic: olanzapine
NDC Package

Package Facts

Identity

Package NDC 50268-615-13
Digits Only 5026861513
Product NDC 50268-615
Description

30 BLISTER PACK in 1 BOX (50268-615-13) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50268-615-11)

Marketing

Marketing Status
Marketed Since 2014-04-23
Brand olanzapine
Generic olanzapine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2b4a7d93-e91a-27be-e063-6294a90a1db0", "openfda": {"nui": ["N0000175430"], "unii": ["N7U69T4SZR"], "rxcui": ["312076", "314155", "351107"], "spl_set_id": ["98697cfd-5521-f8a9-af17-555031690b08"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX (50268-615-13)  / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50268-615-11)", "package_ndc": "50268-615-13", "marketing_start_date": "20140423"}], "brand_name": "OLANZAPINE", "product_id": "50268-615_2b4a7d93-e91a-27be-e063-6294a90a1db0", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "50268-615", "generic_name": "OLANZAPINE", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OLANZAPINE", "active_ingredients": [{"name": "OLANZAPINE", "strength": "5 mg/1"}], "application_number": "ANDA091415", "marketing_category": "ANDA", "marketing_start_date": "20140423", "listing_expiration_date": "20261231"}